ATXI
Avenue Therapeutics Inc
-19.85%
$1.31 - $1.05
Feb 7th 2023 - Mar 21st 2023
Jan, 18, 2023
$ATXI Avenue Therapeutics up Further 14% Pre-mark... See more
Dec, 29, 2022
$KPRX Kiora, Ardelyx $ARDX and Avenue Therapeuti... See more
AKBA
Akebia Therapeutics Inc.
-38.05%
$1.13 - $0.70
Feb 7th 2023 - Mar 21st 2023
Jan, 22, 2023
butler, ceo of akebia therapeutics, exuded confide... See more
Dec, 19, 2022
This results in a cash per share ratio of 0.78, wh... See more
No reviews available.
Jan, 18, 2023
$ATXI Avenue Therapeutics up Further 14% Pre-market https://whatstocksmove.com/atxi-avenue-therapeutics-up-further-14-pre-market/540/
Dec, 29, 2022
$KPRX Kiora, Ardelyx $ARDX and Avenue Therapeutics $ATXI are looking good!
Oct, 23, 2022
$KPRX $ATXI Kiora Pharmaceuticals Phase 1 Human trials successful, NASDAQ compliance sorted, super low float which mean this is a very promising and volatile stock.
Sep, 30, 2022
$ATXI REPEAT Again: Avenue Therapeutics Shareas Surge 160% By Josh Beckerman Avenue Therapeutics Inc. shares were up 160% to $9.16 on volume of more than 41.2 million shares, compared with a 65-day average of .
Jan, 22, 2023
butler, ceo of akebia therapeutics, exuded confidence about his company’s prospects in the coming year.
Dec, 19, 2022
This results in a cash per share ratio of 0.78, which makes it an attractive takeover target, given it will continue generating positive cash flow.” Akebia Therapeutics - well positioned to exploit volatility, financially stable, positive cash flow.
Oct, 20, 2022
Akebia Therapeutics @akebiatx 2h An evening celebrating the dedication and persistence of those in the #kidney community is an evening well spent.